脱髄性疾患における腫瘍壊死因子とインターフェロンの組み合わせ

Title:

脱髄性疾患における腫瘍壊死因子とインターフェロンの組み合わせ

Document Type and Number:

Japanese Patent JP4490104

Kind Code:

B2

Abstract:

The invention relates to the use of an agent having, stimulating or maintaining tumor necrosis factor (TNF) activity, together with an interferon (IFN) for treating and/or preventing demyelinating diseases, in particular multiple sclerosis (MS). The use of a combination of a TNF or a tumor necrosis factor binding protein in combination with an interferon for treating and/or preventing demyelinating diseases is preferred.

More Like This:

WO/2001/035998	COMPOSITIONS FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION OF THERAPEUTIC AGENTS
JPH01102100	HUMAN INTERFERON BETA HAVING SUGAR CHAIN
JP2014207906	STRUCTURE AND USE OF 5' PHOSPHATE OLIGONUCLEOTIDES

Inventors:

Durka, Jean Clown

Application Number:

JP2003565586A

Publication Date:

June 23, 2010

Filing Date:

January 29, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ares Trading Society Anonym

International Classes:

A61K38/21; A61K45/00; A61K31/57; A61K38/00; A61K38/17; A61K38/19; A61K38/22; A61P25/00; A61P25/28; A61P43/00

Domestic Patent References:

JP6503320A
JP11501306A
JP62242629A
JP61015842A
JP2001515047A

Foreign References:

WO2001060392A1

Other References:

医学のあゆみ,1990年 3月10日,Vol.152 No.10,第635頁

Attorney, Agent or Firm:

Atsushi Aoki
Takashi Ishida
Tetsuji Koga
Masaya Nishiyama

Previous Patent: ポンプ

Next Patent: 高分子アパーチャマスクを介して堆積基板上に材料を堆積する方法